SLNSW-Inhibiting IDO pathways to treat cancer: lessons ...-TN_cdi_proquest_journals_2101673945

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Full title: Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Author/creator: Muller, Alexander J., Manfredi, Mark G., Zakharia, Yousef, Prendergast, George C..

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2101673945

Language: English

Formats: Articles

Publishers: Berlin/Heidelberg: Springer Berlin Heidelberg

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101673945

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

    Record identifier

    TN_cdi_proquest_journals_2101673945

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101673945

    Share

    Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101673945

    Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

    Full title

    Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

    Author / Creator

    Muller, Alexander J. ; Manfredi, Mark G. ; Zakharia, Yousef ; Prendergast, George C.

    Publisher

    Berlin/Heidelberg: Springer Berlin Heidelberg

    Journal title

    Seminars in immunopathology, 2019, Vol.41 (1), p.41-48

    Record Identifier

    TN_cdi_proquest_journals_2101673945

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biomedical and Life Sciences Biomedicine Cancer Clinical trials DNA damage Drug Resistance, Neoplasm Enzymes Humans Immune checkpoint Immune response Immunology Immunosuppressive agents Immunotherapy Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism Internal Medicine Melanoma Molecular Targeted Therapy Monoclonal antibodies Neoplasms - drug therapy Neoplasms - etiology Neoplasms - metabolism Neoplasms - pathology PD-1 protein Pembrolizumab Programmed Cell Death 1 Receptor - antagonists & inhibitors Review Signal Transduction - drug effects Targeted cancer therapy Treatment Outcome Tryptophan Tryptophan - metabolism Tryptophan 2,3-dioxygenase Tumor Escape - immunology Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2101673945

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2101673945

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections